MRI pre-treatment (n = 33) | MRI post-treatment (n = 33) | p-value | ||
---|---|---|---|---|
cT stage | < 0.001 | |||
T0 | 0 | 4 (12.1) | ||
T1 | 0 | 0 | ||
T2 | 5 (15.2) | 9 (27.3) | ||
T3A/B | 11 (33.3) | 8 (24.2) | ||
T3C/D | 7 (21.2) | 4 (12.1) | ||
T4A | 6 (18.2) | 5 (15.2) | ||
T4B | 4 (12.1) | 3 (9.1) | ||
cN stage | < 0.001 | |||
N0 | 10 (30.3) | 25 (75.8) | ||
N1 | 12 (36.4) | 5 (15.2) | ||
N2 | 11 (33.3) | 3 (9.1) | ||
MRF involvement | 0.12 | |||
Yes | 17 (51.5) | 13 (39.4) | ||
No | 16 (48.5) | 20 (60.6) | ||
mrTRG | ||||
Grade 1 | 4 (12.1) | |||
Grade 2 | 5 (15.2) | |||
Grade 3 | 15 (45.5) | |||
Grade 4 | 8 (24.2) | |||
Grade 5 | 1 (3.0) |